×
About 58,402 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  28,041 results

HCV virology and diagnosis.
https://doi.org/10.1016/j.clinre.2021.101626
Clinics and Research in Hepatology and Gastroenterology; Roger S, Ducancelle A et. al.

Feb 26th, 2021 - Hepatitis C virus (HCV) infection is a major cause of severe liver disease including chronic hepatitis, cirrhosis and hepatocellular carcinoma. The HCV burden in public health is estimated at about 71 million people worldwide by World Health Organ...

Seroprevalence of Hepatitis C in Children without Identifiable Risk-Factors: A Systemat...
https://doi.org/10.1097/MPG.0000000000003099
Journal of Pediatric Gastroenterology and Nutrition; Melikoki V, Kourlaba G et. al.

Feb 26th, 2021 - Hepatitis C virus (HCV) remains a major public health burden for more than 30 years since its discovery. It is estimated that more than 80 million people have been already infected. DAA treatment is now approved for young children over the age of ...

Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages ...
https://doi.org/10.1002/cncr.33377
Cancer Shaltiel T, Zheng S et. al.

Feb 25th, 2021 - In the United States, mortality after a diagnosis of hepatocellular carcinoma (HCC) is higher in patients who are Black than in patients of other racial groups. The objective of this study was to clarify factors contributing to this disparity by a...

Elevation of Plasminogen Activator Inhibitor-1 promotes differentiation of Cancer Stem-...
https://doi.org/10.1128/JVI.02057-20
Journal of Virology; Nam DE, Angelucci A et. al.

Feb 25th, 2021 - Plasminogen activator inhibitor-1 (PAI-1) is a critical factor that regulates protein synthesis and degradation. The increased PAI-1 levels are detectable in the serum of patients with chronic hepatitis C virus (HCV) liver disease. The differentia...

Hepatitis C related cognitive impairment: impact of viral and host factors and response...
https://doi.org/10.1111/jvh.13492
Journal of Viral Hepatitis; Bar N, Levy S et. al.

Feb 24th, 2021 - Chronic hepatitis C virus (HCV) infection is associated with cognitive impairment via several suggested mechanisms including direct neurotoxicity and minimal hepatic encephalopathy. The prevalence of HCV related cognitive impairment and whether it...

see more →

Guidelines  51 results

Fibrosis regression after eradication of hepatitis C virus - from bench to bedside.
https://doi.org/10.1053/j.gastro.2020.09.065
Gastroenterology Rockey DC, Friedman SL

Feb 2nd, 2021 - Hepatitis C virus (HCV) infection and its complications have been the major cause of cirrhosis and its complications for several decades in the Western world. Until recently, treatment for HCV with interferon-based regimens was associated with mod...

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
https://annals.org/aim/fullarticle/2751913/prevention-diagnosis-evaluation-treatment-hepatitis-c-virus-infection-chronic-kidney

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chro...
https://doi.org/10.7326/M19-1539
Annals of Internal Medicine; Gordon CE, Berenguer MC et. al.

Sep 23rd, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

Aug 27th, 2019 - The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or li...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  28,989 results

HCV virology and diagnosis.
https://doi.org/10.1016/j.clinre.2021.101626
Clinics and Research in Hepatology and Gastroenterology; Roger S, Ducancelle A et. al.

Feb 26th, 2021 - Hepatitis C virus (HCV) infection is a major cause of severe liver disease including chronic hepatitis, cirrhosis and hepatocellular carcinoma. The HCV burden in public health is estimated at about 71 million people worldwide by World Health Organ...

Seroprevalence of Hepatitis C in Children without Identifiable Risk-Factors: A Systemat...
https://doi.org/10.1097/MPG.0000000000003099
Journal of Pediatric Gastroenterology and Nutrition; Melikoki V, Kourlaba G et. al.

Feb 26th, 2021 - Hepatitis C virus (HCV) remains a major public health burden for more than 30 years since its discovery. It is estimated that more than 80 million people have been already infected. DAA treatment is now approved for young children over the age of ...

Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages ...
https://doi.org/10.1002/cncr.33377
Cancer Shaltiel T, Zheng S et. al.

Feb 25th, 2021 - In the United States, mortality after a diagnosis of hepatocellular carcinoma (HCC) is higher in patients who are Black than in patients of other racial groups. The objective of this study was to clarify factors contributing to this disparity by a...

Elevation of Plasminogen Activator Inhibitor-1 promotes differentiation of Cancer Stem-...
https://doi.org/10.1128/JVI.02057-20
Journal of Virology; Nam DE, Angelucci A et. al.

Feb 25th, 2021 - Plasminogen activator inhibitor-1 (PAI-1) is a critical factor that regulates protein synthesis and degradation. The increased PAI-1 levels are detectable in the serum of patients with chronic hepatitis C virus (HCV) liver disease. The differentia...

Hepatitis C related cognitive impairment: impact of viral and host factors and response...
https://doi.org/10.1111/jvh.13492
Journal of Viral Hepatitis; Bar N, Levy S et. al.

Feb 24th, 2021 - Chronic hepatitis C virus (HCV) infection is associated with cognitive impairment via several suggested mechanisms including direct neurotoxicity and minimal hepatic encephalopathy. The prevalence of HCV related cognitive impairment and whether it...

see more →

News  1,285 results

HCV Declines Level Off in HIV+ Men Who Have Sex With Men
https://www.medscape.com/viewarticle/943804

Jan 10th, 2021 - NEW YORK (Reuters Health) - The incidence of hepatitis C virus (HCV) infection among HIV-positive men who have sex with men in the Netherlands fell once direct-acting antivirals (DAAs) became universally available in 2015, new findings show. While...

One-Year Transplant Outcomes Similar With Kidneys From HCV+, HCV- Donors
https://www.medscape.com/viewarticle/942667

Dec 15th, 2020 - NEW YORK (Reuters Health) - Outcomes for renal transplants from hepatitis C virus (HCV)-infected donors to HCV-negative recipients are similar to those for HCV-negative patients who receive kidneys from donors without HCV, according to a one-year ...

Patients Cured of HCV Still at High Liver Cancer Risk
https://www.medscape.com/viewarticle/941615

Nov 25th, 2020 - NEW YORK (Reuters Health) - The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests. "The new hep...

Combo DAA Treatments May Benefit Patients With Resistant HCV Genotype 3
https://www.medscape.com/viewarticle/941464

Nov 22nd, 2020 - Patients with hepatitis C virus (HCV) genotype 3 infection have shown resistance to direct-acting antiviral (DAA) treatments. However, a meta-analysis of 34 research reports found that DAA combo treatment can be effective in achieving sustained vi...

Opt-Out Policy at a Syringe Service Program Increased HIV/HCV Testing
https://www.staging.medscape.com/viewarticle/941269

Nov 18th, 2020 - Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program. Researchers conducted a retrospective comparative analysis o...

see more →

Patient Education  3 results see all →